Annual CFF
$40.37 M
+$39.47 M+4386.00%
December 1, 2023
Summary
- As of February 7, 2025, RCEL annual cash flow from financing activities is $40.37 million, with the most recent change of +$39.47 million (+4386.00%) on December 1, 2023.
- During the last 3 years, RCEL annual CFF has fallen by -$23.68 million (-36.96%).
- RCEL annual CFF is now -47.61% below its all-time high of $77.06 million, reached on June 30, 2020.
Performance
RCEL Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CFF
$1.01 M
+$158.00 K+18.61%
September 1, 2024
Summary
- As of February 7, 2025, RCEL quarterly cash flow from financing activities is $1.01 million, with the most recent change of +$158.00 thousand (+18.61%) on September 1, 2024.
- Over the past year, RCEL quarterly CFF has dropped by -$38.42 million (-97.45%).
- RCEL quarterly CFF is now -98.69% below its all-time high of $76.86 million, reached on December 31, 2019.
Performance
RCEL Quarterly CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM CFF
$41.92 M
+$407.00 K+0.98%
September 1, 2024
Summary
- As of February 7, 2025, RCEL TTM cash flow from financing activities is $41.92 million, with the most recent change of +$407.00 thousand (+0.98%) on September 1, 2024.
- Over the past year, RCEL TTM CFF has increased by +$1.54 million (+3.83%).
- RCEL TTM CFF is now -46.00% below its all-time high of $77.63 million, reached on March 31, 2020.
Performance
RCEL TTM CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash From Financing Formula
CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities
RCEL Cash From Financing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +4386.0% | -97.5% | +3.8% |
| 3 y3 years | -37.0% | +10000.0% | -34.6% |
| 5 y5 years | +35.9% | -98.4% | -34.7% |
RCEL Cash From Financing Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | >+9999.0% | -97.5% | -100.0% | -34.6% | >+9999.0% |
| 5 y | 5-year | -47.6% | >+9999.0% | -98.7% | >+9999.0% | -46.0% | >+9999.0% |
| alltime | all time | -47.6% | >+9999.0% | -98.7% | +180.9% | -46.0% | >+9999.0% |
AVITA Medical Cash From Financing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | $1.01 M(+18.6%) | $41.92 M(+1.0%) |
| Jun 2024 | - | $849.00 K(+34.5%) | $41.51 M(+1.7%) |
| Mar 2024 | - | $631.00 K(-98.4%) | $40.83 M(+1.1%) |
| Dec 2023 | $40.37 M(+4386.0%) | $39.43 M(+6472.0%) | $40.37 M(+2093.0%) |
| Sep 2023 | - | $600.00 K(+250.9%) | $1.84 M(+48.3%) |
| Jun 2023 | - | $171.00 K(0.0%) | $1.24 M(+16.0%) |
| Mar 2023 | - | $171.00 K(-81.0%) | $1.07 M(+18.9%) |
| Dec 2022 | $900.00 K(>+9900.0%) | $899.00 K(>+9900.0%) | $900.00 K(>+9900.0%) |
| Sep 2022 | - | $0.00(0.0%) | $1000.00(-75.0%) |
| Jun 2022 | - | $0.00(-100.0%) | $4000.00(-88.6%) |
| Mar 2022 | - | $1000.00(-66.7%) | $35.00 K(-99.9%) |
| Dec 2021 | $7000.00(-100.0%) | - | - |
| Sep 2021 | - | $3000.00(-90.3%) | $64.06 M(+0.0%) |
| Jun 2021 | $64.05 M(-16.9%) | $31.00 K(-100.0%) | $64.05 M(-0.2%) |
| Mar 2021 | - | $64.03 M(<-9900.0%) | $64.17 M(>+9900.0%) |
| Dec 2020 | - | -$5000.00(+25.0%) | $208.00 K(-99.7%) |
| Sep 2020 | - | -$4000.00(-102.6%) | $77.07 M(+0.0%) |
| Jun 2020 | $77.06 M(+159.4%) | $152.00 K(+133.8%) | $77.06 M(-0.7%) |
| Mar 2020 | - | $65.00 K(-99.9%) | $77.63 M(+0.1%) |
| Dec 2019 | - | $76.86 M(<-9900.0%) | $77.57 M(+373.6%) |
| Sep 2019 | - | -$17.00 K(-102.3%) | $16.38 M(-0.1%) |
| Jun 2019 | $29.71 M(+39.5%) | $725.50 K(-95.4%) | $16.40 M(-33.6%) |
| Dec 2018 | - | $15.67 M(+73.6%) | $24.70 M(+14.9%) |
| Jun 2018 | $21.30 M(+236.4%) | $9.03 M(-27.6%) | $21.49 M(+14.3%) |
| Dec 2017 | - | $12.46 M(+96.9%) | $18.80 M(+214.9%) |
| Jun 2017 | $6.33 M(-9.4%) | $6.33 M(-1852.2%) | $5.97 M(-10.0%) |
| Dec 2016 | - | -$361.30 K(-105.2%) | $6.63 M(-52.4%) |
| Jun 2016 | $6.99 M | $6.99 M(+0.7%) | $13.93 M(+81.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2015 | - | $6.94 M(+816.4%) | $7.70 M(+916.4%) |
| Jun 2015 | $4.30 M(-51.6%) | $757.40 K(-160.9%) | $757.40 K(-85.6%) |
| Jun 2013 | $8.88 M(-9242.4%) | -$1.24 M(-119.1%) | $5.26 M(-17.9%) |
| Dec 2012 | - | $6.50 M(-6797.6%) | $6.41 M(-5152.3%) |
| Jun 2012 | -$97.10 K(-100.7%) | -$97.10 K(+226.9%) | -$126.80 K(-101.0%) |
| Dec 2011 | - | -$29.70 K(-100.2%) | $12.14 M(+2.1%) |
| Jun 2011 | $12.96 M(+590.0%) | $12.17 M(-4447.9%) | $11.89 M(-6998.2%) |
| Dec 2010 | - | -$279.80 K(-360.3%) | -$172.30 K(-128.9%) |
| Jun 2010 | $1.88 M(-980.3%) | $107.50 K(-78.0%) | $595.90 K(+91.2%) |
| Dec 2009 | - | $488.40 K(-376.4%) | $311.70 K(-271.1%) |
| Jun 2009 | -$213.30 K(+2011.9%) | -$176.70 K(+3112.7%) | -$182.20 K(+1602.8%) |
| Dec 2008 | - | -$5500.00(+5.8%) | -$10.70 K(+105.8%) |
| Jun 2008 | -$10.10 K(-100.1%) | -$5200.00(<-9900.0%) | -$5200.00(-101.0%) |
| Dec 2007 | - | $0.00(-100.0%) | $501.80 K(-95.3%) |
| Jun 2007 | $10.85 M(+56.6%) | $501.80 K(-95.0%) | $10.59 M(+5.0%) |
| Dec 2006 | - | $10.09 M(-3786.5%) | $10.09 M(-3786.5%) |
| Jun 2006 | $6.92 M(+44.3%) | - | - |
| Dec 2005 | - | -$273.60 K(-154.6%) | -$273.60 K(-154.6%) |
| Jun 2004 | $4.80 M(+771.5%) | - | - |
| Dec 2003 | - | $501.00 K | $501.00 K |
| Dec 2002 | $550.60 K(-50.8%) | - | - |
| Dec 2001 | $1.12 M(-73.0%) | - | - |
| Dec 2000 | $4.16 M(+56.1%) | - | - |
| Dec 1999 | $2.66 M(>+9900.0%) | - | - |
| Dec 1997 | $0.00(0.0%) | - | - |
| Dec 1996 | $0.00(-100.0%) | - | - |
| Dec 1995 | $186.10 K(-27.3%) | - | - |
| Dec 1994 | $256.00 K(-95.7%) | - | - |
| Dec 1993 | $5.93 M | - | - |
FAQ
- What is AVITA Medical annual cash flow from financing activities?
- What is the all time high annual CFF for AVITA Medical?
- What is AVITA Medical annual CFF year-on-year change?
- What is AVITA Medical quarterly cash flow from financing activities?
- What is the all time high quarterly CFF for AVITA Medical?
- What is AVITA Medical quarterly CFF year-on-year change?
- What is AVITA Medical TTM cash flow from financing activities?
- What is the all time high TTM CFF for AVITA Medical?
- What is AVITA Medical TTM CFF year-on-year change?
What is AVITA Medical annual cash flow from financing activities?
The current annual CFF of RCEL is $40.37 M
What is the all time high annual CFF for AVITA Medical?
AVITA Medical all-time high annual cash flow from financing activities is $77.06 M
What is AVITA Medical annual CFF year-on-year change?
Over the past year, RCEL annual cash flow from financing activities has changed by +$39.47 M (+4386.00%)
What is AVITA Medical quarterly cash flow from financing activities?
The current quarterly CFF of RCEL is $1.01 M
What is the all time high quarterly CFF for AVITA Medical?
AVITA Medical all-time high quarterly cash flow from financing activities is $76.86 M
What is AVITA Medical quarterly CFF year-on-year change?
Over the past year, RCEL quarterly cash flow from financing activities has changed by -$38.42 M (-97.45%)
What is AVITA Medical TTM cash flow from financing activities?
The current TTM CFF of RCEL is $41.92 M
What is the all time high TTM CFF for AVITA Medical?
AVITA Medical all-time high TTM cash flow from financing activities is $77.63 M
What is AVITA Medical TTM CFF year-on-year change?
Over the past year, RCEL TTM cash flow from financing activities has changed by +$1.54 M (+3.83%)